Precious metal powder catalysts are used in the synthesis of pharmaceuticals, fine chemicals, and industrial chemicals, where performance criteria such as high selectivity, activity, and filterability are demanded. Some examples of the variety of applications of these catalysts include the highly selective synthesis of pharmaceutical active ingredients, and the production of precursors for polyurethanes which are further processed into such applications as foams for car seats and furniture.
Evonik is a worldwide leader in precious metal powder catalysts and currently has manufacturing facilities at four locations: Hanau (Germany); Tsukuba (Japan); Americana (Brazil); and Calvert City (Kentucky, U.S.). The pharmaceutical and fine chemicals industries are currently growing at annual rates of more than 15 percent in China. A key advantage of the Shanghai site is its proximity to the Jiangsu and Zhejiang provinces, where a number of pharmaceutical and fine chemical companies are located.
“We will be able to supply customers directly in China with our high-quality precious metal catalysts from the new plant,” said Dr. Hans-Josef Ritzert, head of the Catalysts Business Line of Evonik Industries. “This will allow us to serve our global customers and grow with them in China, and further expand our worldwide leading position.”
In addition, an important aspect of the use of precious metal powder catalysts is precious metal recycling, which Evonik will also offer in China through its existing partnership with Heraeus. This will provide a complete precious metal service enabling customers to optimize their supply chain efficiencies.
Evonik is a leading supplier of catalytic system solutions. It offers an extensive range of heterogeneous and certain homogeneous catalysts from a single source, as well as integrated services for customers from the life sciences, fine chemicals, industrial chemicals, chemical intermediates, and polymers industries.